乳酸/白蛋白比值对院外心脏骤停临床结局的预后价值:一项前瞻性多中心观察性研究(koCARC)
本研究基于韩国心脏骤停研究联盟(koCARC)2015年10月至2017年6月的前瞻性多中心登记数据,纳入524例院外心脏骤停自主循环恢复后患者,评估乳酸/白蛋白比值(LAR)对出院时良好神经结局和生存的预后价值。结果显示,LAR升高与良好神经结局降低(OR 0.787;95%CI 0.630-0.983;P=0.035)和出院生存降低(OR 0.744;95%CI 0.638-0.867;P<0.001)显著相关。LAR预测神经结局和出院生存的AUC分别为0.824和0.781,最佳截断值分别为2.82和3.62。基于多变量逻辑模型构建的列线图预测良好神经结局和出院生存的AUC分别为0.927和0.872。作者结论认为LAR的预后效能优于单独乳酸测量,新建列线图可快速预测临床结局概率。
要点
- 在院外心脏骤停自主循环恢复后患者中,乳酸/白蛋白比值升高与良好神经结局降低独立相关(OR 0.787;95%CI 0.630-0.983;P=0.035)。
- 乳酸/白蛋白比值升高与出院生存降低独立相关(OR 0.744;95%CI 0.638-0.867;P<0.001)。
- 乳酸/白蛋白比值预测良好神经结局的AUC为0.824(P<0.001),预测出院生存的AUC为0.781(P<0.001)。
- 乳酸/白蛋白比值预测良好神经结局和出院生存的最佳截断值分别为2.82和3.62,超过上述值可显著改善对相应结局的预测。
- 基于多变量逻辑模型构建的列线图预测良好神经结局和出院生存的AUC分别为0.927(P<0.001)和0.872(P<0.001)。
适用人群与场景
- 院外心脏骤停后自主循环恢复的患者。
诊断标准与关键阈值
- 乳酸/白蛋白比值预测良好神经结局的最佳截断值为2.82。
- 乳酸/白蛋白比值预测出院生存的最佳截断值为3.62。
研究设计与关键结果
- 研究类型为前瞻性多中心观察性研究,使用韩国心脏骤停研究联盟(koCARC)登记数据,纳入524例院外心脏骤停自主循环恢复后患者。
- 乳酸/白蛋白比值升高与良好神经结局降低显著相关(OR 0.787;95%CI 0.630-0.983;P=0.035)。
- 乳酸/白蛋白比值升高与出院生存降低显著相关(OR 0.744;95%CI 0.638-0.867;P<0.001)。
- 乳酸/白蛋白比值预测良好神经结局的AUC为0.824(P<0.001),预测出院生存的AUC为0.781(P<0.001)。
- 乳酸/白蛋白比值超过最佳截断值2.82和3.62可分别显著改善对良好神经结局降低和出院生存降低的预测。
- 基于多变量逻辑模型构建的列线图预测良好神经结局的AUC为0.927(P<0.001),预测出院生存的AUC为0.872(P<0.001)。
证据类型、等级与局限
- 证据类型:前瞻性多中心观察性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为,乳酸/白蛋白比值的预后效能优于单独乳酸测量,可用于预测院外心脏骤停自主循环恢复后患者的良好神经结局和出院生存。
- 作者认为新建列线图可快速预测临床结局概率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: We aimed to evaluate the lactate/albumin ratio (LAR) to identify its significance as a prognostic marker for favorable neurologic outcome and survival in patients with return of spontaneous circulation after out-of-hospital cardiac arrest (OHCA). Based on the LAR and multiple parameters, we developed new nomograms and externally validated the tools.
METHODS: We conducted an observational study using a prospective, multicenter registry of out-of-cardiac arrest resuscitation provided by the Korean Cardiac Arrest Research Consortium registry from October 2015 to June 2017.
RESULTS: A total of 524 patients were included in this study. An increased LAR was significantly associated with decreased favorable neurologic outcomes (odds ratio [OR] 0.787; 95% confidence interval [CI], 0.630-0.983; P = 0.035) and survival at discharge (OR 0.744; 95% CI, 0.638-0.867; P < 0.001). The areas under the curve (AUCs) for predicting neurologic outcome and survival to discharge using the LAR were 0.824 (P < 0.001) and 0.781 (P < 0.001), respectively. An LAR value of more than the optimal cutoff values of 2.82 and 3.62 could significantly improve prediction of decreased favorable neurologic outcome and survival to discharge, respectively. We constructed nomograms based on the multivariate logistic model. The model for predicting favorable neurologic outcomes and survival discharge had AUCs of 0.927 (P < 0.001) and 0.872 (P < 0.001), respectively.
CONCLUSION: The prognostic performance of the LAR was superior to a single measurement of lactate for predicting favorable neurologic outcomes and survival to discharge after OHCA. The newly developed nomograms can provide rapid prediction of probability of clinical outcomes.
参考来源
- Kong T, Chung SP, Lee HS, et al. The Prognostic Usefulness of the Lactate/Albumin Ratio for Predicting Clinical Outcomes in Out-of-Hospital Cardiac Arrest: a Prospective, Multicenter Observational Study (koCARC) Study. Shock. 2020. PMID: 31306348. doi:10.1097/SHK.0000000000001405
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。